Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Ellwardt

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Der Nervenarzt|July 30, 2020
[Granulomatosis with polyangiitis and neurological disease onset]Erik Ellwardt, Frank Birklein
Experimental Neurology|February 18, 2014
Molecular mechanisms linking neuroinflammation and neurodegeneration in MSErik Ellwardt, Frauke Zipp
Neuroscience Research|September 24, 2017
Role of the epigenetic factor Sirt7 in neuroinflammation and neurogenesisNicolas Burg, Stefan Bittner, Erik Ellwardt
European Journal of Pain (London, England)|April 13, 2020
Heterogeneous presentation of caspr2 antibody-associated peripheral neuropathy - A case seriesErik Ellwardt, Christian Geber, Johannes Lotz, et al.
Der Nervenarzt|November 10, 2019
[CLIPPERS syndrome with supratentorial and spinal cord involvement and histological anomalies]Erik Ellwardt, Tristan Klodt, Clemens Sommer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 1, 2018
Monitoring B-cell repopulation after depletion therapy in neurologic patientsErik Ellwardt, Lea Ellwardt, Stefan Bittner, et al.
Trends in Immunology|January 19, 2016
Understanding the Role of T Cells in CNS HomeostasisErik Ellwardt, James T Walsh, Jonathan Kipnis, et al.
Cytokine & Growth Factor Reviews|August 26, 2014
IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developmentsDirk W Luchtman, Erik Ellwardt, Catherine Larochelle, et al.
European Journal of Pharmacology|January 22, 2020
Targeting CD52 does not affect murine neuron and microglia functionErik Ellwardt, Christina Francisca Vogelaar, Carlos Maldet, et al.
Journal of Neurochemistry|December 15, 2015
In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicityDirk Luchtman, René Gollan, Erik Ellwardt, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Der Nervenarzt|July 30, 2020
[Granulomatosis with polyangiitis and neurological disease onset]Erik Ellwardt, Frank Birklein
Experimental Neurology|February 18, 2014
Molecular mechanisms linking neuroinflammation and neurodegeneration in MSErik Ellwardt, Frauke Zipp
Neuroscience Research|September 24, 2017
Role of the epigenetic factor Sirt7 in neuroinflammation and neurogenesisNicolas Burg, Stefan Bittner, Erik Ellwardt
European Journal of Pain (London, England)|April 13, 2020
Heterogeneous presentation of caspr2 antibody-associated peripheral neuropathy - A case seriesErik Ellwardt, Christian Geber, Johannes Lotz, et al.
Der Nervenarzt|November 10, 2019
[CLIPPERS syndrome with supratentorial and spinal cord involvement and histological anomalies]Erik Ellwardt, Tristan Klodt, Clemens Sommer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 1, 2018
Monitoring B-cell repopulation after depletion therapy in neurologic patientsErik Ellwardt, Lea Ellwardt, Stefan Bittner, et al.
Trends in Immunology|January 19, 2016
Understanding the Role of T Cells in CNS HomeostasisErik Ellwardt, James T Walsh, Jonathan Kipnis, et al.
Cytokine & Growth Factor Reviews|August 26, 2014
IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developmentsDirk W Luchtman, Erik Ellwardt, Catherine Larochelle, et al.
European Journal of Pharmacology|January 22, 2020
Targeting CD52 does not affect murine neuron and microglia functionErik Ellwardt, Christina Francisca Vogelaar, Carlos Maldet, et al.
Journal of Neurochemistry|December 15, 2015
In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicityDirk Luchtman, René Gollan, Erik Ellwardt, et al.
Pageof 3